Professional Documents
Culture Documents
Finance
Perspectives on Corporate Finance and Strategy
Number 57, Winter 2016
2
Valuing high-tech companies
9
M&A 2015: New highs, and a new tone
12
How the best acquirers excel at integration
18
Pharma M&A: Agile shouldnt mean ad hoc
McKinsey on Finance is a
quarterly publication written by
corporate-finance experts
and practitioners at McKinsey
& Company. This publication
offers readers insights into
value-creating strategies and
the translation of those
strategies into company
performance.
This and archived issues of
McKinsey on Finance
are available online at
mckinsey.com, where selected
articles are also available
in audio format. A series of
McKinsey on Finance
podcasts is available
on iTunes.
Editorial Contact:
McKinsey_on_Finance@
McKinsey.com
To request permission to
republish an article, send an
email to Quarterly_Reprints@
McKinsey.com.
Table of contents
Valuing high-tech
companies
It might feel positively retro to
apply discounted-cashflow valuation to hot start-ups
and the like. But its still the
most reliable method.
12
18
It might feel positively retro to apply discounted-cash-flow valuation to hot start-ups and the like. But its still
the most reliable method.
Exhibit
Online media
Traditional media
140
Businesses captured on
Yelp site: 2 million
120
100
80
Yelp accounts:
84,000
60
40
20
0
Source: BIA/Kelsey; Yelp 10-K, 2014; Yelp investor deck, Mar 2014
2013
2015E
2017E
Blackred/Getty Images
M&A 2015:
New highs, and a new tone
Deal activity surged againespecially big deals and those in the United States.
MoF 2016
M&A 2015
Exhibit 1 of 2
Exhibit 1
4,894
4,499
670
3,154
236
1,943
1,220
1,699
1,885
1999
2007
1,130
AsiaPacific
1,147
3,560
2,504
2,669
806
507
569
970
761
804
1,236
1,296
2012
2013
2,617 Americas
1,784
20152
2014
MoF 2016
M&A 2015
Exhibit 2 of 2
1 Includes deals with value of more than $25 million only. Figures may not sum, because of rounding.
2 Data extrapolated to show expected results for entire year based on announced activity (not withdrawn) through Nov 30, 2015.
Exhibit 2
10
5
Total DVA
0
5
Acquirer DVA
10
15
20
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
1 For M&A involving publicly traded companies; dened as combined (acquirer and target) change in market capitalization,
adjusted for market movements, from 2 days prior to 2 days after announcement, as % of transaction value.
10
2014
YTD
20152
and a companys excess total return to shareholders two years after a deal, when most synergies
are captured.
Why do many investors continue to applaud big
deals? It could be a change in the types of deals. In
the past, big deals were often seen as tactics to
address cost reduction and industry consolidation
and many still are. But today we also see deals
where managers and boards are talking about diversification and, for the first time in a long time,
about revenueabout cross-selling and creating
new customer opportunities, and about transformation. Some of that has always been part of the
rationale for big deals, but given continuing strong
announcement effects, it may be that investors
11
12
13
14
MoF 2016
M&A integration
Exhibit 1 of 2
Exhibit 1
75
59
15
Promote
MoF
2016until it hurts
Compared
with other stages of M&A, integration is
M&A integration
where companies
Exhibit
2 of 2 perceive their capacities and
capabilities to be the most deficient. Survey respondents were 12 to 18 percent less likely to report
Exhibit 2
Companies that meet or surpass their M&A objectives are more effective than others
at staffing integration.
% of respondents who strongly agree or agree with descriptions
of how their companies staff integration
81
76
72
46
42
High performers1
Staffs integration
with people who
have right skills
Low performers2
67
42
Staffs integration
with best subjectmatter experts
47
Staffs integration
with right number
of people
1 Companies where respondents to a survey on global M&A capabilities report that those companies have met or surpassed their cost- and
2 Companies where respondents report that those companies have achieved neither their cost- nor revenue-synergy targets in their
transactions (n = 302).
16
High-performing acquirers understand the complexity and importance of getting all aspects of
integration right. Companies that apply best practices
tailored to deal objectives have the best chance of
delivering on the full potential of the deal.
17
isak55/Getty Images
Pharma M&A:
Agile shouldnt mean ad hoc
Under pressure to be active acquirers, some pharmaceutical and medical-products companies may be
neglecting best practices. Heres where they can most improve.
18
The spate of recent megamergers among both pharmaceutical and medical-products (PMP) companies
has made for eye-opening headlines, not just
for the supersizing of these industry-consolidating
deals, but also because it seemed to mark a
break from the industrys usual pattern of M&A. In
the background, though, most PMP companies
continued their usual focus on the rapid completion
of many smaller deals to acquire innovation and
fill selected portfolio and capability gaps.1
Exhibit 1
All respondents,
n = 1,587
PMP companies,
n = 31
52
44
47
44
10%
39
30
32%
43%
25
Identifying targets
26
33%
Negotiating
terms of deal
19
MoF 2016
M&A healthcare
Exhibit 2 of 2
Exhibit 2
33%
35%
44%
36
PMP companies,
n = 31
60
57
55
All respondents,
n = 1,587
40
32
20
descriptions, descriptions of deal owners and crossfunctional deal teams, and common tools. And
even with some standardization, managers still have
the option of pulling in appropriate subjectmatter experts from across the organization.
The lack of standardization is apparent in how
M&A practitioners in PMP companies perceive
their performance in discrete M&A-related
activities. When looking across the target-sourcing
process, the survey finds that PMP companies
see themselves as outperforming the cross-sector
average in activities that are more execution
oriented, but not in activities more closely oriented
to defined processes or playbooks. While
this could be the result of either fewer attempts
to standardize processes or less success
when attempting to do so, the relative lack of
standardization is clear.
21
22
3 For more, see Rebecca Doherty, Spring Liu, and Andy West,
23
24
Podcasts
Learn more about these and other
topics on the McKinsey on Finance
podcast, available on iTunes or
mckinsey.com. Check back frequently
for new content.
currency risk
Werner Rehm
David Wessels
scenario planning
to understand?
Andy West
communicating in turnarounds
CFO attention
the discussion.
infrastructure projects
stock market.
deals ahead.
Robert Palter
during turnarounds
Changing course demands an intense
shareholder activists
long-term value.
Doug Yakola
January 2016
Designed by Global Editorial Services
Copyright McKinsey & Company